APA (7th ed.) Citation

R, C., E, G., T, T., HF, P., PA, G., SM, B., & AM, K. (2025). Recombinant BCG Expressing IL-12 as A Novel Immunomodulatory Strategy for Allergic Asthma: Opportunities and Challenges. Clinical reviews in allergy & immunology, 68(1), 54. https://doi.org/10.1007/s12016-025-09066-x

Chicago Style (17th ed.) Citation

R, Campos-Povea, González-Madrid E, Troncoso-Bravo T, Peñaloza HF, González PA, Bueno SM, and Kalergis AM. "Recombinant BCG Expressing IL-12 as A Novel Immunomodulatory Strategy for Allergic Asthma: Opportunities and Challenges." Clinical Reviews in Allergy & Immunology 68, no. 1 (2025): 54. https://doi.org/10.1007/s12016-025-09066-x.

MLA (9th ed.) Citation

R, Campos-Povea, et al. "Recombinant BCG Expressing IL-12 as A Novel Immunomodulatory Strategy for Allergic Asthma: Opportunities and Challenges." Clinical Reviews in Allergy & Immunology, vol. 68, no. 1, 2025, p. 54, https://doi.org/10.1007/s12016-025-09066-x.